caris life sciences ipo nasdaq

News

Caris Life Sciences Rings Opening Bell

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite for biotech IPOs.

The Dallas Morning News on MSN · 17h

Caris Life Sciences spikes by over 30% in IPO debut, embraces AI as future of oncology

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and

Reuters on MSN · 15h

Caris Life raises $494 million in US IPO

Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering, the cancer diagnostic firm said on Tuesday, amid a rebound in the IPO market. Investors have shown renewed interest in U.

The Pharma Letter1h

BRIEF—Caris shares up by a third on Nasdaq debut

Caris Life Sciences shares ended trading at $28 per share on Wednesday, marking a 33% increase from its initial public offering (IPO) price of $21 per share.

21h

DFW's newest public co. raises $494 million in IPO

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

pharmaphorum2d

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results